We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+4.02%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.55B
AUM Growth
+$1.25B
Cap. Flow
+$1.17B
Cap. Flow %
15.46%
Top 10 Hldgs %
9.43%
Holding
2,269
New
635
Increased
628
Reduced
448
Closed
556

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.48%
2 Financials 13.24%
3 Healthcare 12.6%
4 Technology 12.25%
5 Industrials 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGNE icon
1626
Neurogene
NGNE
$696M
$118K ﹤0.01%
2,218
+858
+63% +$224K
RRD
1627
DELISTED
RR Donnelley & Sons Co.
RRD
$117K ﹤0.01%
20,277
-103,094
-84% -$761K
DX
1628
Dynex Capital
DX
$2.99B
$116K ﹤0.01%
5,900
+767
+15% +$15K
FSP
1629
Franklin Street Properties
FSP
$44.8M
$116K ﹤0.01%
+13,523
New +$107K
OVID icon
1630
Ovid Therapeutics
OVID
$435M
$115K ﹤0.01%
+14,700
New +$126K
BRG
1631
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$115K ﹤0.01%
+12,897
New +$115K
ELGX
1632
DELISTED
Endologix Inc
ELGX
$115K ﹤0.01%
2,039
-2,829
-58% -$143K
KEYW
1633
DELISTED
The KEYW Holding Corporation
KEYW
$114K ﹤0.01%
+13,000
New +$109K
RIOT icon
1634
Riot Platforms
RIOT
$8.52B
$112K ﹤0.01%
17,603
-4,897
-22% -$35.8K
ORC
1635
Orchid Island Capital
ORC
$1.31B
$111K ﹤0.01%
+2,945
New +$109K
TXMD icon
1636
TherapeuticsMD
TXMD
$23.8M
$109K ﹤0.01%
348
-986
-74% -$301K
RMTI icon
1637
Rockwell Medical
RMTI
$26.2M
$108K ﹤0.01%
+199
New +$119K
GALT icon
1638
Galectin Therapeutics
GALT
$229M
$105K ﹤0.01%
+16,578
New +$80.7K
TNAV
1639
DELISTED
Telenav Inc.
TNAV
$105K ﹤0.01%
18,753
+3,453
+23% +$18.8K
XIN
1640
DELISTED
Xinyuan Real Estate
XIN
$103K ﹤0.01%
+2,319
New +$121K
NEOS
1641
DELISTED
Neos Therapeutics, Inc
NEOS
$103K ﹤0.01%
16,500
+4,300
+35% +$32.1K
RBBN icon
1642
Ribbon Communications
RBBN
$354M
$102K ﹤0.01%
14,314
-3,060
-18% -$17.9K
GAU
1643
Galiano Gold
GAU
$486M
$100K ﹤0.01%
+93,699
New +$106K
AFH
1644
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$98K ﹤0.01%
+11,232
New +$119K
SEAC
1645
DELISTED
Seachange International Inc
SEAC
$95K ﹤0.01%
1,390
-2,115
-60% -$129K
ZIXI
1646
DELISTED
Zix Corporation
ZIXI
$95K ﹤0.01%
+17,694
New +$91K
BW icon
1647
Babcock & Wilcox
BW
$1.43B
$94K ﹤0.01%
+3,969
New +$105K
CLNE icon
1648
Clean Energy Fuels
CLNE
$447M
$94K ﹤0.01%
25,492
-792
-3% -$1.87K
GOGL
1649
DELISTED
Golden Ocean Group
GOGL
$93K ﹤0.01%
+10,685
New +$89.7K
TALO.WS
1650
DELISTED
Talos Energy, Inc. Warrants to purchase common stock (expiring February 28, 2021)
TALO.WS
$91K ﹤0.01%
+19,146
New +$96.5K

Similar funds

Squarepoint's Q2 2018 Portfolio in Review

As of Q2 2018, Squarepoint held 2,269 positions worth $7.55B, up 20% from $6.3B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Squarepoint deployed $1.17B of net new capital in Q2 2018, opening 635 new positions and adding to 628 existing holdings. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI India ETF, an estimated $47.3M trimmed.

  • Squarepoint's largest Q2 2018 buy was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.
  • Squarepoint added most to iShares MSCI Taiwan ETF in Q2 2018, an estimated $102M increase.
  • Squarepoint's biggest Q2 2018 reduction was iShares MSCI India ETF, cutting an estimated $47.3M.
  • Squarepoint fully exited iShares MSCI Brazil ETF in Q2 2018, selling an estimated $119M.
  • Squarepoint's ten largest holdings make up 9.4% of its $7.55B portfolio in Q2 2018.
  • Squarepoint opened 635 new positions and closed 556 in Q2 2018.
  • Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.55B.

Based on Squarepoint's 13F filing for Q2 2018, filed 14 Aug 2018.